| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7d3453606e8227232796b781d08ad6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ea6004bccc0b2e41c4deda386d29b4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-36 |
| filingDate |
2016-01-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_551464b58703a22dd91e737d1bd897a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e477e08676d9436c3e31a4e492a4139f |
| publicationDate |
2016-07-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016208231-A1 |
| titleOfInvention |
Dimeric bacteriophage lysins |
| abstract |
The present invention provides isolated dimeric Streptococcus -specific phage lysins having two Streptococcus -specific phage lysin monomers covalently linked to each other, and having killing activity against one or more Streptococcus bacteria. Also provided for are pharmaceutical compositions of dimeric lysins and their use in therapeutic treatment or alleviation of infections or bacterial colonizations. The dimeric lysins may also be used to decontaminate porous and non-porous surfaces or devices. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9789167-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015118189-A1 |
| priorityDate |
2011-10-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |